[Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
Mannessier
L
L
EFS Nord de France, Site de Lille, 21, rue C. Guérin, 59012 Lille Cedex.
Alie-Daram
S
S
Roubinet
F
F
Valat
A S
AS
Depoortère
M H
MH
Fournié
A
A
Puech
F
F
D001788:Blood Grouping and Crossmatching; D004899:Erythroblastosis, Fetal / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D049590:Postpartum Period; D011247:Pregnancy; D012203:Rh Isoimmunization / Q000150:complications / Q000517:prevention & control; D018029:Rho(D) Immune Globulin / Q000008:administration & dosage / Q000627:therapeutic use
D018029:Rho(D) Immune Globulin